|
|
Post by hellodolly on Nov 9, 2023 15:44:00 GMT -5
The last seven trading days, 23M shares have traded with an average of 3.28M daily. Thats ~500,000 above our 10day average. What was 7 days ago? UTHR EC was seven days ago. Although their SP was choppy, today it was in a free fall. What else can we overlay with this information over the last few days. The XBI was down two days ago ~2.5% and today ~4.4% with a roughly two day decline ~7%.
I'm thankful and optimistic that the SP will resume it's long term upward trend and the shorts were able to gift me shares at these low prices. I know it's early to be giving thanks but, I am grateful.
In conclusion, the tide has gone out this week, UTHR numbers added some pressure and this won't last. Have a blessed weekend.
|
|
|
|
Post by letitride on Nov 9, 2023 15:47:19 GMT -5
Things are looking up already got you posting to the optimism thread. God only knows you might start posting about how your buying shares soon. Lets Go!
|
|
|
|
Optimism
Nov 21, 2023 13:26:54 GMT -5
via mobile
Post by mango on Nov 21, 2023 13:26:54 GMT -5
Seems several people here that are MNKD investors are quite disappointed by results this quarter. Perhaps you could explain what distortion is occurring that has made us disappointed. I'd be glad if someone could explain the slow down in Tyvaso revenue and Mike's comment about merely hovering at breakeven. What is being distorted about that? Please undistort for me. Was Matt that guy that warned MNKD was going to have to dilute a lot... before MNKD diluted a lot? Think he might have predicted the share price would drop below $1... that Matt? Yes, I remember him. It was the Matt that always said MannKind was going to go bankrupt and private messaged people on here trying to get them to sell. That Matt. |
|
|
|
Optimism
Nov 21, 2023 14:05:24 GMT -5
via mobile
Post by cretin11 on Nov 21, 2023 14:05:24 GMT -5
Who did Matt private message “trying to get them to sell”? If true, how dare he try to save people from incurring losses on this stock. He never tried to help me like that (but I’m too stubborn and would’ve ignored him anyway).
|
|
|
|
Post by BD on Nov 21, 2023 16:52:58 GMT -5
I sure didn't hear from him lol.
|
|
|
|
Post by sportsrancho on Nov 21, 2023 20:38:20 GMT -5
Almost every company I heard report earnings today talked about a slowdown, and when you give that kind of guidance, the stock slows down, you need a growth story and more buyers.
Vdex is having record revenue days. We have got people coming to our Roswell clinic from an hour and a half away because they’ve heard we are opening up a clinic in their town and they just don’t want to wait.
Prices are falling across the US and we’re going to be buying our next clinic instead of leasing space. Yay:-)
Before we even open the clinics now we go into the town and let everybody in it know who we are. We talk to the Chamber of commerce, Bill meets with the head of the hospitals, we get doctors and hospitals willing to refer to us and we do community events, blood drives, etc. I join their Facebook page for instance. We create anticipation and excitement.
Our next clinic was supposed to be in Hobbs, but because of a special circumstance and opportunity, Hobbs will be a little bit later down the road. We’ll announce where the new clinic is in the first part of January. Along with other developments. As we get further along the clinics will open at a faster pace. This is a recession proof growth story.
|
|
|
|
Post by mymann on Nov 22, 2023 13:05:59 GMT -5
I would be optimistic if I saw Mike buy 10000 shares in open market.
|
|
|
|
Post by radgray68 on Nov 22, 2023 14:44:05 GMT -5
Optimistic events for me, aside from recently being able to load up at $3.41: 1) Patients enrolled in the pump switch trial in record time. Bodes REALLY well for us when we go big with marketing, either internally or with a new big$ partner. 2) The current pediatric trials are going good enough to keep going and they don’t require additional enrollment / money. 3). Revenue is increasingly likely to cover all our costs and fund two more MannKind branded products through to FDA approval. 4). We’ve started chipping away at our debt. 5). We’ve got V-GO ready to take over the world. (Haha, couldn’t resist taking a jab at the anti-V-GO crowd, gotta have my fun  Happy Thanksgiving everyone |
|
|
|
Post by mpg54 on Nov 22, 2023 15:03:32 GMT -5
Almost every company I heard report earnings today talked about a slowdown, and when you give that kind of guidance, the stock slows down, you need a growth story and more buyers. Vdex is having record revenue days. We have got people coming to our Roswell clinic from an hour and a half away because they’ve heard we are opening up a clinic in their town and they just don’t want to wait. Prices are falling across the US and we’re going to be buying our next clinic instead of leasing space. Yay:-) Before we even open the clinics now we go into the town and let everybody in it know who we are. We talk to the Chamber of commerce, Bill meets with the head of the hospitals, we get doctors and hospitals willing to refer to us and we do community events, blood drives, etc. I join their Facebook page for instance. We create anticipation and excitement. Our next clinic was supposed to be in Hobbs, but because of a special circumstance and opportunity, Hobbs will be a little bit later down the road. We’ll announce where the new clinic is in the first part of January. Along with other developments. As we get further along the clinics will open at a faster pace. This is a recession proof growth story. Does Vedex typically treat patients with Afrezza, or is it just used as an option for treatment? I think Vedex sounds great and is most likely serving a real need, but I'm curious how often is Afrezza used for Vedex patients? Also, do patients stay on it, or is it a one time thing for many, they get treated for their high then go back to whatever they were doing. I'm curious, but I realize you may or may not be able to share much. Thanks. |
|
|
|
Post by sportsrancho on Nov 22, 2023 15:10:39 GMT -5
Almost every company I heard report earnings today talked about a slowdown, and when you give that kind of guidance, the stock slows down, you need a growth story and more buyers. Vdex is having record revenue days. We have got people coming to our Roswell clinic from an hour and a half away because they’ve heard we are opening up a clinic in their town and they just don’t want to wait. Prices are falling across the US and we’re going to be buying our next clinic instead of leasing space. Yay:-) Before we even open the clinics now we go into the town and let everybody in it know who we are. We talk to the Chamber of commerce, Bill meets with the head of the hospitals, we get doctors and hospitals willing to refer to us and we do community events, blood drives, etc. I join their Facebook page for instance. We create anticipation and excitement. Our next clinic was supposed to be in Hobbs, but because of a special circumstance and opportunity, Hobbs will be a little bit later down the road. We’ll announce where the new clinic is in the first part of January. Along with other developments. As we get further along the clinics will open at a faster pace. This is a recession proof growth story. Does Vedex typically treat patients with Afrezza, or is it just used as an option for treatment? I think Vedex sounds great and is most likely serving a real need, but I'm curious how often is Afrezza used for Vedex patients? Also, do patients stay on it, or is it a one time thing for many, they get treated for their high then go back to whatever they were doing. I'm curious, but I realize you may or may not be able to share much. Thanks. Sure….Afrezza is our flagship product. We would love it if everyone of our patients was on it because when they get on it, we’ve got 80% retention. But if we can’t get them on it because of cost or insurance then we give them the next best thing for their blood sugar control, and we monitor that. Tight control gives you the lifespan of a non-diabetic and that’s what Afrezza provides. It’s why Bill founded Vdex. |
|
|
|
Post by mpg54 on Nov 22, 2023 15:16:49 GMT -5
Does Vedex typically treat patients with Afrezza, or is it just used as an option for treatment? I think Vedex sounds great and is most likely serving a real need, but I'm curious how often is Afrezza used for Vedex patients? Also, do patients stay on it, or is it a one time thing for many, they get treated for their high then go back to whatever they were doing. I'm curious, but I realize you may or may not be able to share much. Thanks. Sure….Afrezza is our flagship product. We would love it if everyone of our patients was on it because when they get on it, we’ve got 80% retention. But if we can’t get them on it because of cost or insurance then we give them the next best thing for their blood sugar control, and we monitor that. Tight control gives you the lifespan of a non-diabetic and that’s what Afrezza provides. It’s why Bill founded Vdex. Thanks for the quick reply, good to know. |
|
|
|
Post by ktim on Nov 22, 2023 20:22:51 GMT -5
Seems several people here that are MNKD investors are quite disappointed by results this quarter. Perhaps you could explain what distortion is occurring that has made us disappointed. I'd be glad if someone could explain the slow down in Tyvaso revenue and Mike's comment about merely hovering at breakeven. What is being distorted about that? Please undistort for me. Was Matt that guy that warned MNKD was going to have to dilute a lot... before MNKD diluted a lot? Think he might have predicted the share price would drop below $1... that Matt? Yes, I remember him. It was the Matt that always said MannKind was going to go bankrupt and private messaged people on here trying to get them to sell. That Matt. As I remember he just, correctly, stated that there would be dilution that would cause big losses in the equity. The company's own statements had "ongoing concern" warnings... risk of bankruptcy if financing were not to be available. Mike C has now made reference to the dire straits the company was previously in. If Mike had said that back then he basically would have been agreeing with Matt and disagreeing with the Polyannas here. Of course Mike would have been a fool to admit the dire straits the company was in. Matt certainly seemed more correct than most here that expected Afrezza to take off quickly even after Sanofi pulled out... and look at the monthly TRx growth over all those years. He understood the dynamics of the health business here in the US and how that would present an almost insurmountable obstacle for Afrezza to overcome in any reasonable amount of time. If Matt is still private messaging you about risk of bankruptcy 1) I'd have a hard time believing it but 2) would then think he isn't being sincere. He certainly isn't now posting here about MNKD's financials or advising against owning MNKD. Though if you can point to a statement he made that said "MNKD will go bankrupt because they have no chance of dilutive financing." then he would have been wrong on that account. I don't believe he ever said that. I sure wish I'd listened to Matt. Though I've now made back what I'd lost I sure would be much more ahead if I'd heeded his warnings and stayed out of MNKD while he was warning about the dilution. A lot of my shares are now from first half of 2020. I could have avoided a decade of losses and gotten in at a great price point in 2020. Too bad he didn't private message me to sell with a convincing argument. Not sure I would have listened as I was a bit foolish about MNKD back then, but I might have. |
|
|
|
Optimism
Nov 22, 2023 20:52:23 GMT -5
via mobile
Post by sportsrancho on Nov 22, 2023 20:52:23 GMT -5
This was years ago. I believe he told Larry ( RIP ) that. Larry was concerned and told some of us.
|
|
|
|
Post by cretin11 on Nov 23, 2023 3:46:35 GMT -5
Would be curious to know what Matt thinks of MNKD’s prospects now. Like agedhippie, Matt was much maligned but turned out to be one of the more accurate posters here.
|
|
|
|
Post by prcgorman2 on Nov 26, 2023 10:43:33 GMT -5
Would be curious to know what Matt thinks of MNKD’s prospects now. Like agedhippie, Matt was much maligned but turned out to be one of the more accurate posters here. Must’ve moved on for some reason(s). |
|
